Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026
2027
2028
2029
2030
Trend
ROE
-46.55%
-90.92%
-
112.24%
57.5%
38.45%
ROA
-35.09%
-45.95%
-51.4%
-56.96%
-60.77%
-62.52%
Gross Margin
58.05%
58.05%
58.05%
58.05%
58.05%
58.05%
Sector average
16.85%
17.71%
17.71%
17.71%
17.71%
17.71%
Net Margin
-145.7%
-142.11%
-140.91%
-141.64%
-141.51%
Amounts in SEK (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for Vitrolife AB (publ)? It covers the balance sheet, income statement and Equlion model projections.
-141.45%
Total Assets
SEK 11,124.00M
SEK 10,349.65M
SEK 10,755.93M
SEK 11,374.87M
SEK 11,908.29M
SEK 12,216.07M
Sector average
SEK 2,857.19M
SEK 2,900.24M
SEK 3,045.01M
SEK 3,280.29M
SEK 3,536.41M
SEK 3,762.91M
Net Income
-SEK 5,012.00M
-SEK 4,933.99M
-SEK 5,423.83M
-SEK 6,302.66M
-SEK 7,074.55M
-SEK 7,541.13M
Sector average
-SEK 2.85M
-SEK 22.03M
-SEK 0.90M
-SEK 7.25M
-SEK 3.86M
-SEK 1.55M
Valuation
SEK 18,367.26M
SEK 18,081.37M
SEK 19,876.48M
SEK 23,097.10M
SEK 25,925.80M
SEK 27,635.67M
Sector average
SEK 3,960.50M
SEK 5,151.30M
SEK 5,189.24M
SEK 5,317.34M
SEK 5,514.33M
SEK 5,636.78M
Stock Price
SEK 135.60
SEK 133.49
SEK 146.75
SEK 170.52
SEK 191.41
SEK 204.03
Sector average
SEK 57.22
SEK 48.04
SEK 48.69
SEK 50.45
SEK 52.13
SEK 53.41
Vitrolife AB (publ) (VITR.ST) Financial Forecast | Equlion
